AESI | n | Intensive phase | Continuation phase | Overall | ||||
No. | % | No. | % | No. | % | |||
Hepatotoxicitya |
|
|
|
|
|
|
| |
| Elevated SGPT level | 74 | 2 | (2.7) | 0 | 0 | 2 | 2.7 |
| Elevated SGPT level | 74 | 3 | (4.1) | 0 | 0 | 3 | 4.1 |
Renal insufficiencyb |
|
|
|
|
|
|
| |
| Elevated creatinine clearance level | 75 | 1 | (1.3) | 0 | 0 | 1 | 1.3 |
Hearing impairmentc |
|
|
|
|
|
|
| |
| Left ear | 46 | 2 | (4.3) | 0 | 0 | 2 | 4.3 |
| Right ear | 49 | 3 | (6.1) | 0 | 0 | 3 | 6.1 |
QTcF prolongationd | 70 | 18 | (25.7) | 2 | 2.7 | 18 | (25.7) |